Last reviewed · How we verify
Moisturizers
At a glance
| Generic name | Moisturizers |
|---|---|
| Sponsor | Sanofi |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Serial Casting for Upper Extremity Burn Contractures (NA)
- Metronidazole SC Penetrance With Moisturizers (NA)
- Facial Muscle Exercises vs Fractional Microneedling Radiofrequency for Facial Rejuvenation (NA)
- Improving Women's Function After Pelvic Radiation (NA)
- Complete Decongestive Therapy Versus Non-pneumatic Compression Therapy in Post Mastectomy Lymphedema (NA)
- Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2) (PHASE3)
- Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME) (PHASE3)
- Evaluate the Feasibility and Effectiveness of a Community-based Care Bundle in Managing and Preventing Pressure Injuries (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Moisturizers CI brief — competitive landscape report
- Moisturizers updates RSS · CI watch RSS
- Sanofi portfolio CI